Business Context and Reporting Period
Company: ANAVEX LIFE SCIENCES CORP.
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2014
Event: The Company entered into a Securities Purchase Agreement to raise capital through the issuance of Senior Convertible Debentures and Warrants.
Key Financial Metrics
Capital Raised: $10,000,000 in gross proceeds (consummated March 18, 2014).
Debt Issued: Senior Convertible Debentures with an aggregate principal amount of $10,000,000.
Equity Instruments: Warrants to purchase up to 67,666,666 shares of common stock.
Interest: No regularly scheduled interest payments on the Debentures.
Liquidity Impact: Immediate cash inflow of $10,000,000 prior to transaction expenses.
Material Changes and Transaction Terms
- Debenture Terms: 30-year term; unsecured; convertible at an initial price of $0.30 per share. The Company may optionally redeem the Debentures at 110% of the outstanding principal plus accrued amounts.
- Default Provisions: Upon an "Event of Default," the "Mandatory Default Amount" is triggered, calculated as the greater of a conversion-based value or 130% of the principal plus 100% of accrued interest.
- Warrant Structure:
- Series A: 33,333,333 shares at $0.30 exercise price (5-year term).
- Series B: 33,333,333 shares at $0.42 exercise price (5-year term).
- Registration Rights: The Company must file a registration statement within 30 days and achieve effectiveness within 60-90 days. Failure to do so incurs a penalty of 1.5% of the purchase price per month.
Outlook, Risks, and Contingencies
Management Commentary: The filing focuses on the execution of the financing agreement and does not provide specific operational guidance or future earnings projections.
Risks:
- Dilution: Significant potential dilution exists due to the conversion of $10 million in debt at $0.30 and the exercise of warrants for 67.7 million shares.
- Default Penalty: The "Mandatory Default Amount" could significantly increase the Company's liability in the event of a default.
- Registration Penalty: Failure to timely register the securities results in ongoing cash penalties (1.5% monthly).
Investor Verification Checklist
- Verify the exact amount of agent fees and transaction expenses deducted from the $10,000,000 gross proceeds.
- Confirm the current number of outstanding shares to assess the immediate dilution impact of the 67,666,666 warrant shares and potential debt conversion.
- Review the specific covenants and definitions of "Event of Default" in the attached Debenture agreement (Exhibit 10.3).
- Monitor the status of the Registration Statement filing to ensure the 1.5% monthly penalty is avoided.